385 related articles for article (PubMed ID: 31173991)
1. Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
Borody TJ; Eslick GD; Clancy RL
Curr Opin Pharmacol; 2019 Dec; 49():43-51. PubMed ID: 31173991
[TBL] [Abstract][Full Text] [Related]
2. Expert opinion on fecal microbiota transplantation for the treatment of
Kumar V; Fischer M
Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
[No Abstract] [Full Text] [Related]
3. Fecal microbiota transplantation: past, present and future perspectives.
Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
[TBL] [Abstract][Full Text] [Related]
4. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
[TBL] [Abstract][Full Text] [Related]
5. [Faecal microbiota transplantation for the treatment of bowel disease].
Rode AA; Chehri M; Petersen AM; Bytzer P
Ugeskr Laeger; 2017 Jul; 179(31):. PubMed ID: 28869008
[TBL] [Abstract][Full Text] [Related]
6. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Mahmoudi H; Hossainpour H
Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458
[TBL] [Abstract][Full Text] [Related]
7. Clinical Application and Potential of Fecal Microbiota Transplantation.
Ooijevaar RE; Terveer EM; Verspaget HW; Kuijper EJ; Keller JJ
Annu Rev Med; 2019 Jan; 70():335-351. PubMed ID: 30403550
[TBL] [Abstract][Full Text] [Related]
8. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
Patwa SA; Ward C; Kelly CR
R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
[TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
Kelly CR; Yen EF; Grinspan AM; Kahn SA; Atreja A; Lewis JD; Moore TA; Rubin DT; Kim AM; Serra S; Nersesova Y; Fredell L; Hunsicker D; McDonald D; Knight R; Allegretti JR; Pekow J; Absah I; Hsu R; Vincent J; Khanna S; Tangen L; Crawford CV; Mattar MC; Chen LA; Fischer M; Arsenescu RI; Feuerstadt P; Goldstein J; Kerman D; Ehrlich AC; Wu GD; Laine L
Gastroenterology; 2021 Jan; 160(1):183-192.e3. PubMed ID: 33011173
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation beyond Clostridioides difficile infections.
Wortelboer K; Nieuwdorp M; Herrema H
EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
[TBL] [Abstract][Full Text] [Related]
12. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation.
Vindigni SM; Surawicz CM
Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW
J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
[TBL] [Abstract][Full Text] [Related]
16. Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.
Dawwas GK; Brensinger CM; Vajravelu RK; Wu Q; Kelly CR; Laine L; Wu GD; Lewis JD
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):806-816.e6. PubMed ID: 33307184
[TBL] [Abstract][Full Text] [Related]
17. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease.
Basson AR; Zhou Y; Seo B; Rodriguez-Palacios A; Cominelli F
Transl Res; 2020 Dec; 226():1-11. PubMed ID: 32585148
[TBL] [Abstract][Full Text] [Related]
18. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
Newman KM; Rank KM; Vaughn BP; Khoruts A
Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
